methoxyhydroxyphenylglycol has been researched along with Akinetic-Rigid Variant of Huntington Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bezprozvanny, I; Chan, EY; Hayden, MR; Maximov, A; Tang, TS; Tu, H; Wang, Z; Wellington, CL | 1 |
| Bezprozvanny, I; Chan, EY; Hayden, MR; Orban, PC; Tang, TS; Tu, H | 1 |
| Mayeux, R | 1 |
| Albano, C; Bacigalupo, F; Bartolini, A; Farinini, D; Firpo, MP; Pizio, N; Roccatagliata, G | 1 |
| Abbruzzese, G; Albano, C; La Medica, G; Loeb, C; Roccatagliata, G | 1 |
| Vestergaard, P; Yates, CM | 1 |
| Lindvall, B; Olsson, JE | 1 |
| Chase, TN; Gordon, EK; Ng, LK | 1 |
| Bertilsson, L; Mattsson, B | 1 |
1 review(s) available for methoxyhydroxyphenylglycol and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Behavioral manifestations of movement disorders. Parkinson's and Huntington's disease.
Topics: Adult; Aged; Dementia; Depression; Depressive Disorder; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Intelligence; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Personality | 1984 |
8 other study(ies) available for methoxyhydroxyphenylglycol and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1.
Topics: Action Potentials; Animals; Blotting, Western; Calcium; Calcium Channels; Calcium Signaling; Cells, Cultured; Cerebellum; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Fura-2; Green Fluorescent Proteins; Humans; Huntingtin Protein; Huntington Disease; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Lipid Bilayers; Luminescent Proteins; Methoxyhydroxyphenylglycol; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Patch-Clamp Techniques; Peptide Fragments; Plasmids; Protein Binding; Receptors, Cytoplasmic and Nuclear; Recombinant Proteins; Time Factors; Two-Hybrid System Techniques | 2003 |
HAP1 facilitates effects of mutant huntingtin on inositol 1,4,5-trisphosphate-induced Ca release in primary culture of striatal medium spiny neurons.
Topics: Animals; Calcium; Cells, Cultured; Corpus Striatum; Huntington Disease; Inositol 1,4,5-Trisphosphate; Kinetics; Lipid Bilayers; Membrane Glycoproteins; Membrane Transport Proteins; Methoxyhydroxyphenylglycol; Mice; Mice, Knockout; Nerve Tissue Proteins; Neurons; Serotonin Plasma Membrane Transport Proteins | 2004 |
[Effect of fenfluramine in Huntington Chorea].
Topics: 5-Hydroxytryptophan; Adult; Female; Fenfluramine; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged | 1983 |
Levodopa and Huntington's chorea.
Topics: Adult; Female; Homovanillic Acid; Humans; Huntington Disease; Levodopa; Methoxyhydroxyphenylglycol; Middle Aged; Pedigree; Serotonin | 1976 |
Amine metabolites in cerebrospinal fluid from Huntigton's chorea patients treated with lithium.
Topics: Adult; Biogenic Amines; Double-Blind Method; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Lithium; Male; Methoxyhydroxyphenylglycol; Middle Aged | 1978 |
Monoamine metabolites and neuropeptides in patients with Parkinson's disease, Huntington's chorea, Shy-Drager syndrome, and torsion dystonia.
Topics: Dystonia Musculorum Deformans; Enkephalin, Methionine; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Neuropeptides; Neurotransmitter Agents; Parkinson Disease; Shy-Drager Syndrome; Somatostatin | 1990 |
Norepinephrine metabolism in the central nervous system of man: studies using 3-methoxy-4-hydroxyphenylethylene glycol levels in cerebrospinal fluid.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Carbon Radioisotopes; Cerebrospinal Fluid; Child; Chromatography, Gas; Dihydroxyphenylalanine; Dopamine; Down Syndrome; Dystonia Musculorum Deformans; Female; Glycols; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Methyltyrosines; Middle Aged; Norepinephrine; Parkinson Disease; Picolinic Acids; Probenecid; Serotonin; Spinal Cord Diseases; Time Factors | 1973 |
Treatment with disulfiram in huntington's chorea.
Topics: Adult; Aged; Disulfiram; Dopamine beta-Hydroxylase; Female; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Indoleacetic Acids; Male; Methoxyhydroxyphenylglycol; Middle Aged; Motor Activity; Stimulation, Chemical | 1974 |